The Health Products Regulatory Authority has published the 106th edition of its Drug Safety Newsletter. 

The latest edition includes information on review of the latest evidence on risks associated with in-utero exposure to phenytoin, phenobarbital, carbamazepine, pregabalin and valproate.

For further details please click here.